Dicerna Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 40 U.S.-traded ETFs. DRNA has around 4.2M shares in the U.S. ETF market. The largest ETF holder of DRNA is the iShares Russell 2000 ETF (IWM), with approximately 1.18M shares. Investors may also find of interest that the ETF with the largest allocation to DRNA stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 1.72%. On average, U.S. ETFs allocate 0.23% of DRNA to their portfolios.
Additionally, DRNA is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with DRNA as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.